Larimar’s Upcoming Regulatory Milestones and Strong Balance Sheet Highlight Momentum in Friedreich’s Ataxia Program
Market Chameleon (Fri, 15-May 10:59 AM)
Breakthrough Therapy Designation and Strong Cash Position Set Stage for Larimar’s Next Chapter in Rare Disease Innovation
Market Chameleon (Fri, 20-Mar 10:49 AM)
